|
⚲
|
| Keyboard |
| Prelude Therapeutics Inc
✚
|
|
|---|---|
| CIK # | 0001678660 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 10-K | [0001678660] | |
| 10-Q | [0001678660] | |
| 3 | [0001678660] | |
| 4 | [0001678660] | |
| 8-K | [0001678660] | |
| D | [0001678660] | |
| SC 13D | [0001678660] | |
| SC 13G | [0001678660] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Prelude Therapeutics Inc PRLD
Employee Stock Option (right to buy) · derivative
|
2026-02-04 | Grant | 230,000 | $0.00 | |
|
Prelude Therapeutics Inc PRLD
Employee Stock Option (right to buy) · derivative
|
2026-02-04 | Grant | 230,000 | $0.00 | |
|
Prelude Therapeutics Inc PRLD
Employee Stock Option (right to buy) · derivative
|
2026-02-04 | Grant | 275,000 | $0.00 | |
|
Prelude Therapeutics Inc PRLD
Employee Stock Option (right to buy) · derivative
|
2026-02-04 | Grant | 837,000 | $0.00 | |
|
Prelude Therapeutics Inc PRLD
Director Stock Option (Right to Buy) · derivative
|
2025-11-05 | Grant | 121,285 | $0.00 | |
|
Prelude Therapeutics Inc PRLD
Director Stock Option (Right to Buy) · derivative
|
2025-10-17 | Grant | 76,000 | $0.00 | |
|
Prelude Therapeutics Inc PRLD
Common Stock
|
2025-10-04 | Tax withheld | 3,355 | $1.47 | 4,932 |
|
Prelude Therapeutics Inc PRLD
Common Stock
|
2025-10-04 | Option exercise | 9,375 | ||
|
Prelude Therapeutics Inc PRLD
Restricted Stock Unit · derivative
|
2025-10-04 | Option exercise | 9,375 | $0.00 | |
|
Prelude Therapeutics Inc PRLD
Common Stock
|
2025-07-04 | Option exercise | 9,375 | ||
|
Prelude Therapeutics Inc PRLD
Common Stock
|
2025-07-04 | Tax withheld | 3,355 | $0.79 | 2,650 |
|
Prelude Therapeutics Inc PRLD
Restricted Stock Unit · derivative
|
2025-07-04 | Option exercise | 9,375 | $0.00 | |
|
Prelude Therapeutics Inc PRLD
Non- Qualified Stock Option (right to buy) · derivative
|
2025-06-12 | Grant | 76,000 | $0.00 | |
|
Prelude Therapeutics Inc PRLD
Non- Qualified Stock Option (right to buy) · derivative
|
2025-06-12 | Grant | 76,000 | $0.00 | |
|
Prelude Therapeutics Inc PRLD
Director Stock Option (Right to Buy) · derivative
|
2025-06-12 | Grant | 38,000 | $0.00 | |
|
Prelude Therapeutics Inc PRLD
Director Stock Option (Right to Buy) · derivative
|
2025-06-12 | Grant | 38,000 | $0.00 | |
|
Prelude Therapeutics Inc PRLD
Director Stock Option (Right to Buy) · derivative
|
2025-06-12 | Grant | 38,000 | $0.00 | |
|
Prelude Therapeutics Inc PRLD
Director Stock Option (Right to Buy) · derivative
|
2025-06-12 | Grant | 38,000 | $0.00 | |
|
Prelude Therapeutics Inc PRLD
Director Stock Option (Right to Buy) · derivative
|
2025-06-12 | Grant | 38,000 | $0.00 | |
|
Prelude Therapeutics Inc PRLD
Common Stock
|
2025-04-04 | Tax withheld | 3,355 | $0.68 | 2,281 |
| showing 20 of 200 most recent transactions | |||||